What Is Zonulin?

Zonulin is a protein produced by intestinal epithelial cells that modulates the permeability of tight junctions between cells in the intestinal lining. It was discovered by Dr. Alessio Fasano and his team at Harvard Medical School and is currently the only identified physiological regulator of intestinal permeability in humans. When zonulin levels rise, tight junctions open, increasing intestinal permeability. When zonulin levels normalise, tight junctions reseal.

Zonulin is structurally similar to a Vibrio cholerae toxin called zonula occludens toxin (Zot), which is how it was originally discovered. Fasano's group identified zonulin as the human analogue of Zot, and subsequent research has established its role as a key mediator of the gut barrier function that is disrupted in numerous diseases.

What Triggers Zonulin Release?

Two primary stimuli trigger zonulin release from intestinal epithelial cells:

Gluten (Gliadin)

Gliadin, the alcohol-soluble fraction of gluten, binds to the CXCR3 receptor on intestinal epithelial cells, triggering zonulin release. This occurs in individuals with celiac disease, non-celiac gluten sensitivity, and, to a lesser degree, in some healthy individuals. The resulting increase in intestinal permeability allows gliadin peptides to cross the gut barrier and interact with the immune system in the lamina propria, potentially initiating or perpetuating the autoimmune cascade in celiac disease.

Bacterial Exposure

When bacteria (or bacterial components) contact the apical surface of small intestinal epithelial cells, zonulin is released. This is thought to be a protective mechanism: by opening tight junctions, the gut flushes bacteria and potential pathogens out through increased fluid secretion. In acute settings, this is beneficial. In chronic dysbiosis (where bacterial overgrowth or imbalanced microbiome composition provides constant stimulation), zonulin remains chronically elevated, leading to sustained increased intestinal permeability.

Diseases Associated with Elevated Zonulin

Research has linked elevated zonulin levels to numerous conditions:

  • Celiac disease — the condition where the zonulin pathway is most extensively characterised
  • Type 1 diabetes — elevated zonulin precedes disease onset in genetically susceptible individuals
  • Autoimmune diseases — including Hashimoto's, rheumatoid arthritis, multiple sclerosis, and lupus
  • Inflammatory bowel disease — both Crohn's disease and ulcerative colitis
  • IBS — particularly the diarrhoea-predominant subtype
  • Metabolic syndrome and obesity — zonulin correlates with insulin resistance and visceral fat accumulation
  • Neurological conditions — depression, anxiety, and neurodegenerative diseases
Fasano's research suggests that increased intestinal permeability (mediated by zonulin) may be a prerequisite for autoimmune disease development, not merely a consequence. This means that normalising zonulin levels could potentially prevent autoimmune progression in at-risk individuals.

Testing Zonulin

Zonulin can be measured in blood (serum) or stool (faecal). Each has advantages:

  • Serum zonulin — reflects systemic zonulin levels; available through most functional medicine laboratories. Normal ranges vary by lab but typically fall below 50 ng/mL
  • Faecal zonulin — measured in stool samples, often as part of comprehensive stool panels. May more accurately reflect intestinal zonulin release than serum levels

Limitations of Zonulin Testing

It is important to understand the current limitations:

  • Most commercial zonulin assays measure a family of related proteins (haptoglobin-2 and pre-haptoglobin-2) rather than zonulin specifically, which can affect test accuracy
  • Reference ranges are not fully standardised across laboratories
  • A normal zonulin level does not definitively rule out increased intestinal permeability, as other pathways can compromise tight junctions independently of zonulin
  • Zonulin is a snapshot in time and can fluctuate with meals, stress, and infections

Strategies to Reduce Elevated Zonulin

If your zonulin levels are elevated, several evidence-based strategies can help normalise them:

  • Gluten removal or reduction — if gluten is a primary trigger, removing it eliminates a major stimulus for zonulin release
  • Address SIBO — bacterial overgrowth in the small intestine provides chronic stimulation of zonulin release; treating SIBO can normalise levels
  • Zinc supplementation — zinc is essential for tight junction protein synthesis; zinc carnosine (75mg twice daily) has specific evidence for improving intestinal permeability
  • Glutamine — the primary fuel for enterocytes; 5-10g daily supports gut barrier integrity
  • Reduce ultra-processed food consumption — emulsifiers and additives directly increase intestinal permeability
  • Manage stress — cortisol degrades tight junction proteins through a zonulin-independent but additive mechanism

GutIQ's assessment evaluates symptoms associated with increased intestinal permeability, helping you determine whether zonulin testing and barrier-repair strategies should be a priority in your gut health plan.